cognitive cybersecurity intelligence

News and Analysis

Search

Motif Neurotech Raises $18.75M for Implantable Device for Treatment-Resistant Depression –

Motif Neurotech, a company specialising in bioelectronics for mental health, has raised $18.75m in a series A funding round. The money will be used to advance clinical development of its DOT microstimulator, a device designed to treat treatment-resistant depression (TRD) by stimulating specific brain circuits. The funding will also help the company enhance the device, scale production and distribution.

Source: hitconsultant.net –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

A National Imperative – Cyber Resiliency

Cybersecurity expert Andrea E. Davis emphasizes the increasing vulnerability of critical infrastructure to cyber threats, highlighting instances such as the 2003 US and Canada power